呼吸道支架/肺支架的全球市场规模:各产品，各用途，各地区，范围及预测

气道支架/肺支架市场规模及预测

2024年气道支架/肺动脉支架市场规模为8783万美元，预计到2031年将达到1.4716亿美元，2024年至2031年复合年增长率为6.68%，预计将会增长。全球气道支架/肺动脉支架市场的推动因素包括：治疗肺癌等疑难杂症的MIS（微创手术）需求不断增加、公共和私人机构对非血管支架开发的研发投资不断增加以及实际应用的需求增加。该研究报告对全球气道支架/肺支架市场进行了全面评估。它对关键细分市场、趋势、市场推动因素、阻碍因素、竞争格局以及在市场中发挥关键作用的因素进行了全面分析。

气道支架/肺支架的全球市场定义

气道支架/肺支架是由各种材料製成的支气管内假体，可支撑空心管状气道结构并保持其通畅。气道支架可以帮助防止肿瘤进展到气道，帮助治癒或控制气道瘻管，或对抗气道壁阻塞和外部焦点。支架由多种材料製成，包括金属和硅胶。它们有各种尺寸和形状。支架的范围从暂时到永久。当存在恶性和良性过程的混合时，进行气道支架置入术。无论适应症如何，在支架置入之前，胸腔外科医师或介入性肺科医师必须确保患者不患有手术可逆的气道疾病。如果支架放置导致病灶超出 4 公分（气管切除术常用的限制），则尤其如此。

气道支架的使用经常会引起一些胸腔外科医师和介入病理学家的肠道反应。这种下意识的反应要不是过去灾难性案例的结果，就是你的导师在你的心灵中根深蒂固的。这些病例需要准确解释具体病例、特定患者可用的选择以及现代气道支架的生物材料和工程背后的硬数据。一般来说，在医学上能够接受外科手术以挽救良性或致命性疾病的患者不应接受受影响的人工气道的放置。如果患者功能严重受损且预期寿命很短，也不应放置支架。

全球气道支架/肺动脉支架市场概况

全球气道支架/肺支架市场主要由用于治疗肺癌、青光眼、慢性阻塞性肺病、中央气道阻塞、气喘等疑难杂症的MIS（微创手术）需求不断增长所推动。一个主要因素。肺癌患者往往患有呼吸道疾病。根据《亚太癌症预防杂誌》报导，大约 30% 的肺癌患者会出现中央气道阻塞 (CAO)，这会导致严重的呼吸道併发症。因此，气道支架的拨款和使用显着增加，并且预计未来将持续下去。公共和私人机构对非血管支架开发的开创性研发投资正在推动市场成长。例如，2020 年 1 月，美国 FDA 批准了一种 3D 列印气道支架，其製造适合患者气道。

此外，技术进步，例如开发创新支架，可以利用物联网和数据科学等先进技术提供呼吸道即时数据，也正在推动全球气道支架市场在估计期间的成长。可生物降解肺支架和药物洗脱肺支架的改进也将扩大气道支架的采用并促进市场成长。然而，与支架置入相关的併发症和几种可用的替代疗法可能会限制特定时期内的市场成长。此外，吸烟率也在下降，这也是市场的阻碍因素。

目录

第1章 呼吸道支架/肺支架的全球市场:简介

• 市场概要
• 调查范围
• 前提条件

第2章 摘要整理

第3章 VERIFIED MARKET RESEARCH的调查手法

• 资料探勘
• 验证
• 一次采访
• 资料来源一览

第4章 呼吸道支架/肺支架的全球市场展望

• 概要
• 市场动态
• 促进因素
• 阻碍因素
• 机会
• 波特的五力分析
• 价值链分析

第5章 呼吸道支架/肺支架的全球市场:各产品

• 气管支架
• 喉支架

第6章 呼吸道支架/肺支架的全球市场:各用途

• 医院
• 门诊病人手术中心

第7章 呼吸道支架/肺支架的全球市场:各地区

• 北美
• 美国
• 加拿大
• 墨西哥
• 欧洲
• 德国
• 英国
• 法国
• 其他欧洲
• 亚太地区
• 中国
• 日本
• 印度
• 其他亚太地区
• 全球其他地区
• 南美
• 中东·非洲

第8章 呼吸道支架/肺支架的全球市场:竞争情形

• 概要
• 企业的市场排行榜
• 主要的开发策略

第9章 企业简介

• Boston Scientific
• C.R. Bard
• Taewoong Medical
• Micro-Tech(南京市)
• Teleflex
• Merit Medical Systems
• Cook Group
• Novatech Sa
• Endo-Flex
• M.I. Tech
• Efer Endoscopy
• Fuji Systems
• Hood Laboratories

第10章 附录

• 相关报告

Airway Stent/Lung Stent Market Size And Forecast

Airway Stent/Lung Stent Market size was valued at USD 87.83 Million in 2024 and is projected to reach USD 147.16 Million by 2031 , growing at a CAGR of 6.68% from 2024 to 2031. The Global Airway Stent/Lung Stent Market has witnessed strong growth owing to the increasing demand for MIS (Minimally Invasive Surgeries) for the treatment of persistent conditions such as lung cancer, growing R&D investments by the public and private organizations for the development of non-vascular stents, and technological advancements such as the development of innovative stents that can offer real-time data of the respiratory tract. The Global Airway Stent/Lung Stent Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global Airway Stent/Lung Stent Market Definition

An airway/lung stent is an endobronchial prosthesis of different materials that supports and preserves the patency of the hollow tubular airway structure. An airway stent may prevent the extension of a tumor into the airway, may help in the healing or control of airway fistulas, or may help the airway wall against failure or external concentration. Stents can be made of various materials, such as metal or silicone. They also come in various sizes and shapes. They can be momentary or permanent. Airway stenting is shown in a mixture of malignant and benign processes. Independent of the indication, before any stent placement, the thoracic surgeon or interventional pulmonologist must be sure that the sufferer does not have any surgically reversible airway disease. Stenting may involve or preclude surgery in some cases, especially when it extends the lesion to >4 cm in length, a generally used limit for tracheal resection.

The use of airway stents often elicits a visceral reaction from some thoracic surgeons and interventional pulmonologists. These reflexive rejoinders are the result of catastrophic cases in the past or are strongly ingrained in their psyche by their instructors. When this occurs, it is necessary to accurately interpret the particular case, the possible options for that special patient, and the solid data behind the biomaterials and engineering of contemporary airway stents. In general, patients medically able to experience surgical interventions to preserve benign or deadly conditions should not have an affected airway prosthesis placed. Also, very close impairment in functional capacity and very short survival expectancy should preclude stenting.

What's inside a VMR industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

Global Airway Stent/Lung Stent Market Overview

The Global Airway Stent/Lung Stent Market is principally driven by increasing demand for MIS (Minimally Invasive Surgeries) for the treatment of persistent conditions including lung cancer, glaucoma, chronic obstructive pulmonary disease, central airway obstruction, asthma, etc. Patients suffering from lung cancer are inclined to suffer from breathing conditions. According to the Asian Pacific Journal of Cancer Prevention, around 30% of the patients suffering from lung cancer occur central airway obstruction (CAO) which results in severe breathing complications. As a result, the appropriation and utilization of airway stents have increased significantly and are anticipated to follow a similar trend in the following years. Growing R&D investments by the public and private organizations for the development of non-vascular stents is besides fueling the market growth. For example, in January 2020, the U.S. FDA approved 3D printed airway stent, which is produced to fit the patient's airway.

Additionally, technological advancements such as the development of innovative stents that can offer real-time data of the respiratory tract using excellent technologies like IoT and Data Science are also adding to the growth of the global airway stenting market during the estimated timeframe. The improvement of biodegradable and drug-eluting lung stents will also expand the adoption of airway stents, thus augmenting the growth of the market. However, complications connected with stent implementation and several alternative treatments available might restrain the growth of the market during the given time frame. Moreover, the pervasiveness of tobacco smoking has also been decreasing, which also acts as a restraint to the market.

Global Airway Stent/Lung Stent Market Segmentation Analysis

The Global Airway Stent/Lung Stent Market Segmented On The Basis Of Product, Application, And Geography.

Airway Stent/Lung Stent Market, By Product

• Tracheal Stents
• Laryngeal Stents
• Bronchial Stents

Based on Product, the market is bifurcated into Tracheal Stents, Laryngeal Stents, and Bronchial stents. The bronchial stent segment is anticipated to grow at the highest CAGR during the forecast period owing to the high adoption of bronchial stents to treat respiratory disorders. Bronchial stents are additionally largely used in the treatment of hemoptysis following lung cancer and in the treatment of progressive dyspnea therefore, there is an enhanced demand for bronchial stents. Furthermore, bronchial stents are favored due to requirements such as palliative relief of symptoms, minimal invasiveness, and decreased chances of risks in surgeries.

Airway Stent/Lung Stent Market, By Application

• Hospitals
• Ambulatory Surgery Centers

Based on Application, the market is bifurcated into Hospitals and Ambulatory Surgery Centers. The Ambulatory Surgery Centers segment is estimated to witness the highest CAGR for the forecast period. Ambulatory surgical centers are more cost-effective than conventional hospitals and provide a shorter duration of stay post-surgery. Moreover, an increment in several ambulatory surgical centers and a rise in choice for minimally invasive surgeries are further factors enlarging the demand for lung stents.

Airway Stent/Lung Stent Market, By Geography

• North America
• Europe
• Asia Pacific
• Rest of the world.

Based on regional analysis, the Global Airway Stent/Lung Stent Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. The North American airway stent market is estimated for the largest revenue share as of 2019 and it is anticipated to maintain its dominance during the forecast period. The presence of significant manufacturers, well-established healthcare infrastructure, and high awareness amongst the doctors ended in the rising adoption of these stents in this region. Moreover, the rising prevalence of diseases, growing geriatric population, and rising healthcare expenditure are also contributing to the growth of the market in this region.

Key Players

• The "Global Airway Stent/Lung Stent Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are
• Boston Scientific, C.R. Bard, Taewoong Medical, Micro-Tech (Nanjing), Teleflex, Merit Medical Systems, Cook Group, Novatech Sa, Endo-Flex, M.I. Tech, Ever Endoscopy, Fuji Systems, Hood Laboratories

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

TABLE OF CONTENTS

1. Introduction of Global Airway Stent/Lung Stent Market

• Overview of the Market
• Scope of Report
• Assumptions

2. Executive Summary

3. Research Methodology of Verified Market Research

• Data Mining
• Validation
• Primary Interviews
• List of Data Sources

4. Global Airway Stent/Lung Stent Market Outlook

• Overview
• Market Dynamics
• Drivers
• Restraints
• Opportunities
• Porters Five Force Model
• Value Chain Analysis

5. Global Airway Stent/Lung Stent Market, By Product

• Tracheal Stents
• Laryngeal Stents

6. Global Airway Stent/Lung Stent Market, By Application

• Hospitals
• Ambulatory Surgery Centres

7. Global Airway Stent/Lung Stent Market, By Geography

• North America
• U.S.
• Canada
• Mexico
• Europe
• Germany
• UK
• France
• Rest of Europe
• Asia Pacific
• China
• Japan
• India
• Rest of Asia Pacific
• Rest of the World
• Latin America
• Middle East & Africa

8. Global Airway Stent/Lung Stent Market Competitive Landscape

• Overview
• Company Market Ranking
• Key Development Strategies

9. Company Profiles

• Boston Scientific
• C.R. Bard
• Taewoong Medical
• Micro-Tech (Nanjing)
• Teleflex
• Merit Medical Systems
• Cook Group
• Novatech Sa
• Endo-Flex
• M.I. Tech
• Efer Endoscopy
• Fuji Systems
• Hood Laboratories

10. Appendix

• Related Reports